Vaccinations

Promising Alzheimer’s vaccine enters phase 1 clinical trial to target tau protein

University of New Mexico researchers are launching a phase 1 clinical trial of a novel Alzheimer’s vaccine designed to clear tau protein.

Google searches for vaccine infertility increased by 34,900% following misinformation incident

Google searches for infertility relating to COVID-19 vaccines increased by 34,900% after a pair of physicians submitted a petition questioning their safety.

How games can be used to combat health and vaccine misinformation

Soraiya Verjee, Business Development Director of Sea Monster, discusses how the use of games and animation can combat COVID-19 and vaccine misinformation.

France and Greece say COVID vaccine mandatory for health workers

France and Greece both made statements yesterday (12 July) declaring that the COVID vaccine was now mandatory for healthcare workers - with French workers losing wages after September, if they don't have a dose.

SAGE data reveals 115,800 more COVID deaths possible by 2022

SAGE reveal that in the most pessimistic scenario, a further 115,800 COVID deaths would happen by June, 2022 - but in the most optimistic 'unlockdown' output, the figure is 9,400 deaths.

FDA labels Johnson & Johnson vaccine with new rare side effect

The FDA have labelled the Johnson & Johnson COVID vaccine as a possible cause of Guillain-Barré syndrome - an extremely rare side effect that can potentially cause nerve damage.

Sinovac vaccine performs at 83.5% in Phase Three trial

New data from Phase Three of the Sinovac vaccine trial shows that the drug is now performing at 83.5%.

Pfizer to create COVID vaccine against Delta variant

Pfizer say they will develop a new COVID vaccine to function as a booster against the Delta variant.

9 in 10 adults have COVID-19 antibodies, according to new survey

A new Government survey has found that 9 in 10 adults have COVID-19 antibodies, but experts say more data is needed before 'Freedom Day'.

Study finds natural immune response not effective against COVID variants

An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.

Supporting vaccination campaigns through high-quality cold storage solutions

Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.

Is the Lambda variant more infectious than Delta?

The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.

SAGE report: More infections will increase ethnic minority COVID deaths

SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.

UK study says saRNA COVID vaccines work in 87% of people

While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.

UK study says safe to mix Pfizer and AstraZeneca doses

A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.

WHO says double-vaccinated people should wear masks

The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.

UK to give third COVID dose for over-50s before winter

The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders